350 related articles for article (PubMed ID: 17020989)
1. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.
Yang Z; Schumaker LM; Egorin MJ; Zuhowski EG; Guo Z; Cullen KJ
Clin Cancer Res; 2006 Oct; 12(19):5817-25. PubMed ID: 17020989
[TBL] [Abstract][Full Text] [Related]
2. Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.
Yang Z; Faustino PJ; Andrews PA; Monastra R; Rasmussen AA; Ellison CD; Cullen KJ
Cancer Chemother Pharmacol; 2000; 46(4):255-62. PubMed ID: 11052622
[TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO.
Kim MM; Glazer CA; Mambo E; Chatterjee A; Zhao M; Sidransky D; Califano JA
Oral Oncol; 2006 Feb; 42(2):201-7. PubMed ID: 16266817
[TBL] [Abstract][Full Text] [Related]
4. Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis.
Zhao M; Mydlarz WK; Zhou S; Califano J
ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):257-63. PubMed ID: 18483464
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells.
Cao J; Liu Y; Jia L; Zhou HM; Kong Y; Yang G; Jiang LP; Li QJ; Zhong LF
Free Radic Biol Med; 2007 Sep; 43(6):968-75. PubMed ID: 17697941
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of rat brain mitochondrial voltage-dependent anion as a potential tool to control leakage of cytochrome c.
Banerjee J; Ghosh S
J Neurochem; 2006 Aug; 98(3):670-6. PubMed ID: 16787424
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.
Ijichi K; Adachi M; Hasegawa Y; Ogawa T; Nakamura H; Kudoh A; Yasui Y; Murakami S; Ishizaki K
Cancer Chemother Pharmacol; 2008 Oct; 62(5):745-52. PubMed ID: 18075740
[TBL] [Abstract][Full Text] [Related]
9. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
[TBL] [Abstract][Full Text] [Related]
11. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis.
Deniaud A; Sharaf el dein O; Maillier E; Poncet D; Kroemer G; Lemaire C; Brenner C
Oncogene; 2008 Jan; 27(3):285-99. PubMed ID: 17700538
[TBL] [Abstract][Full Text] [Related]
13. Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human head and neck carcinoma cells.
Kim HE; Krug MA; Han I; Ensley J; Yoo GH; Forman JD; Kim HR
Clin Cancer Res; 2000 Oct; 6(10):4142-7. PubMed ID: 11051268
[TBL] [Abstract][Full Text] [Related]
14. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in head and neck squamous cell cancer.
Prince ME; Ailles LE
J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
Hirama M; Isonishi S; Yasuda M; Ishikawa H
Oncol Rep; 2006 Nov; 16(5):997-1002. PubMed ID: 17016583
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of cisplatin-induced apoptosis and caspase 3 activation by depletion of mitochondrial DNA in a human osteosarcoma cell line.
Yen HC; Tang YC; Chen FY; Chen SW; Majima HJ
Ann N Y Acad Sci; 2005 May; 1042():516-22. PubMed ID: 15965098
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
20. Association of caspase-8 mutation with chemoresistance to cisplatin in HOC313 head and neck squamous cell carcinoma cells.
Liu J; Uematsu H; Tsuchida N; Ikeda MA
Biochem Biophys Res Commun; 2009 Dec; 390(3):989-94. PubMed ID: 19852930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
